BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25951995)

  • 1. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
    Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
    Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
    Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K
    Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043
    [No Abstract]   [Full Text] [Related]  

  • 7. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
    Hu K; Yu J; Suknuntha K; Tian S; Montgomery K; Choi KD; Stewart R; Thomson JA; Slukvin II
    Blood; 2011 Apr; 117(14):e109-19. PubMed ID: 21296996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon.
    Yusa K; Rad R; Takeda J; Bradley A
    Nat Methods; 2009 May; 6(5):363-9. PubMed ID: 19337237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
    Papapetrou EP; Sadelain M
    Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.
    Sommer CA; Sommer AG; Longmire TA; Christodoulou C; Thomas DD; Gostissa M; Alt FW; Murphy GJ; Kotton DN; Mostoslavsky G
    Stem Cells; 2010 Jan; 28(1):64-74. PubMed ID: 19904830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cells produced under xeno-free conditions.
    Ross PJ; Suhr ST; Rodriguez RM; Chang EA; Wang K; Siripattarapravat K; Ko T; Cibelli JB
    Stem Cells Dev; 2010 Aug; 19(8):1221-9. PubMed ID: 20030562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
    Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
    PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.
    Seki T; Yuasa S; Fukuda K
    Nat Protoc; 2012 Mar; 7(4):718-28. PubMed ID: 22422317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.
    Ban H; Nishishita N; Fusaki N; Tabata T; Saeki K; Shikamura M; Takada N; Inoue M; Hasegawa M; Kawamata S; Nishikawa S
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14234-9. PubMed ID: 21821793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
    Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
    Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
    Qu X; Liu T; Song K; Li X; Ge D
    PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.